Drug intelligence / Profile preview

purified pituitary gonadotropin

Development stage: Unknown
Modality: Recombinant Proteins and Enzymes
Administration: Subcutaneous

Overview

Purified pituitary gonadotropin is a urinary gonadotropin preparation primarily composed of follicle-stimulating hormone (FSH) with very low luteinizing hormone (LH) content. It is used for ovulation induction and follicle development in infertile women, particularly those with ovulatory disorders due to hypothalamic or pituitary dysfunction, amenorrhea I, or anovulatory cycles. It functions by stimulating the development of ovarian follicles. This preparation is commonly used in Japan for treating infertility.

Brand names: Fertinorm-P
Other names: u-hFSH

Targets

FSHR (Follicle-stimulating hormone receptor)

Beyond the preview

Go deeper on purified pituitary gonadotropin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on purified pituitary gonadotropin.

Explore the full profile